Article
Alma Lasers has received clearance from the Food and Drug Administration for its new fractionated skin resurfacing module, the company announced.
Defining Treatment Options for Managing Chronic Atopic Dermatitis
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
Conference Recap: 2024 Society of Dermatology Physician Associates Fall Dermatology Conference
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
New Algorithm Proposes Targeted Lipase Monitoring for Pancreatic Adverse Events In Melanoma
Heart Transplant Recipients are More Susceptible to Skin Cancer